Research news
The latest developments in the search for better treatments and a cure for macular disease.
Latest news
Syfovre FAQs and next steps for dry AMD and geographic atrophy treatment
Posted: Thursday 30 January 2025
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) decision to reject the first potential treatment for geographic atrophy (GA), or late-stage age-related macular degeneration (AMD) is undoubtedly a disappointing one for those living with the condition. But, what does the decision mean? We answer your questions.
First treatment for late-stage dry AMD rejected by UK drug regulator
Posted: Wednesday 22 January 2025
The first potential treatment for geographic atrophy (GA) or late stage dry aged-related macular degeneration has been rejected by the Medicines and Healthcare products Regulatory Agency (MHRA).
How artificial intelligence is transforming eye care
Posted: Thursday 9 January 2025
Artificial intelligence (AI) is already part of our daily lives, but how is it changing healthcare? In a recent webinar hosted by Macular Society partner OcuPlan Dr James Neffendorf, an eye specialist at King’s College Hospital and ophthalmic surgeon Dan Calladine, explored how AI is transforming the way eye care is delivered and how it is improving outcomes for patients.
Daily tablet shows promise as first treatment for Stargardt disease
Posted: Monday 2 December 2024
A new drug for Stargardt disease, called gildeuretinol (ALK-001), has received special recognition from the Food and Drug Administration in the US, highlighting its potential to treat the condition.
First-of-a-kind study shines light on DMO treatment among diverse backgrounds
Posted: Friday 29 November 2024
For the first time, people from underrepresented ethnic and racial backgrounds were the focus of a clinical trial which reported improved vision after receiving treatment for diabetic macular oedema (DMO).
Supplements offer hope for advanced AMD, says researcher
Posted: Monday 25 November 2024
Dr Tiarnan Keenan, a clinician scientist at the National Eye Institute in the US, shares groundbreaking insights into the benefits of AREDS2 supplements for people with geographic atrophy (GA), an advanced stage of dry age-related macular degeneration (AMD).
Explore our research
Beating macular disease through funding medical research and improving the lives of those living with macular disease.
Get involved in research
Patients have a very important part to play in medical research. Without them we would not have the treatments we have today and new and improved treatments would not be possible.
Get the latest research news from the Macular Society
To hear about life-changing research and treatments, subscribe to our monthly enewsletter today. Together we can Beat Macular Disease.
Sign up to our free email newsletter